MAP1LC3B and Alzheimer disease: As can be observed in Fig. 3D and E, we quantified a higher expression (although not statistically significant) of LC3B and its co-localization with TOMM20+ mitochondria in AD astrocytes, showing both markers a significant spatial overlay in the case of AD astrocytes (Fig. 3F).